-
Investigator Awards
BHCRI Funding Opportunities
Investigator awards are currently supported by funds provided by the Dalhousie Medical Research Foundation and the New Brunswick Health Research Foundation.
DMRF can support researchers at Dalhousie University and affiliated health centres (including Dalhousie Medicine New Brunswick). NBHRF funds are to support researchers based at institutions in New Brunswick. BHCRI serves as the peer review mechanism for New Brunswick-based researchers. Recommendations for New Brunswick applicants will be forwarded to NBHRF and final funding decisions will be determined by NBHRF.
Eligible Principal Investigators include Dalhousie (including Dalhousie Medicine New Brunswick) or New Brunswick-based BHCRI Senior Scientists, Scientists, Associate Members or Honorary Members (qualifying as Senior Scientists, Scientists or Associate Members at Dalhousie) in good standing and whose project is clearly focused on cancer.
Seed Funds — Seed funds are meant to provide application support, initial results, or other inputs that are critical to a future funding application of an individual or team, where the absence of these materials or support would greatly compromise the future application. — suspended until further notice
Miscellaneous Funds provide support for immediate need such as KT outputs, training and travel, project planning meetings and publication costs.— suspended until further notice.
Both Seed and Miscellaneous are designed for rapid turnaround and have no set due date. Applications are reviewed by the BHCRI Research Committee at regularly scheduled committee meetings. Please see Research Committee meeting schedule: https://bhcri.ca/committee-meetings
Early Career Awards are offered once per year with a set deadline. Applicants must be withn the first seven years of their initial academic appointmetn and be a member of BHCRI and eligible to hold grant funds. The Early Career Awards will be for $50,000 pear year for two years. As many as three grants per year will be offered with one each to basic, clinical and population researchers, with this last category very broadly defined.— suspended until further notice.
Forms and Guidelines:
• Seed Funds guidelines and application. — suspended until further notice
• Miscellaneous Funds guidelines and application — suspended until further notice.
• Early Career application and review criteria — The 2022 Early Career Awards competition is now closed. — suspended until further notice.
• A completed Funding Overlap Declaration is to be submitted with all applications.
Impact:
How little seeds can grow into something grand
BHCRI’s Seed Grants provide investigators with modest funds to initiate new lines of investigation that position them to go after grant support from national funding organizations. These BHCRI Seed Grants provide investigators with the resource to produce the preliminary data that is so necessary to make applications competitive. Since 2009, BHCRI has invested over $380,000 to support 43 projects. This investment has resulted in over $800,000 in grant support, an impressive 210% return on investment.
A recent success is Dr. Denis Dupre from Dalhousie’s Department of Pharmacology. Dr. Dupre received a $10,000 seed grant in 2019, to investigate the effect of cannabis compounds in bladder cancer. Despite setbacks caused by COVID, including closure of his lab for four months, the preliminary data gathered using resources from the seed grant led to new funding from Bladder Cancer Canada.
“Thanks to the seed grant, so far we have two manuscripts submitted and one successful proposal that resulted from that 10k investment you made in me”, says Dr. Dupre.
Recent publications as a result of funding:
Anticancer properties of cannabidiol and Δ9 -tetrahydrocannabinol and synergistic effects with gemcitabine and cisplatin in bladder cancer cell lines. Erin G. Whynot, Andrea M Tomko and Denis J Dupre.
(2023) Journal of Cannabis Research
Anti-cancer properties of cannflavin A and potential synergistic effects with gemcitabine, cisplatin, and cannabinoids in bladder cancer. Andrea M Tomko, Erin G. Whynot and Denis J Dupre. (2022) Journal of Cannabis Research.
Anti-cancer potential of cannabis terpenes in a taxol-resistant model of breast cancer. Andrea M Tomko, Erin G Whynot, Lauren F O’Leary, Denis J Dupre (2022). Can J Physiol Pharmacol.
Award Recipients:
Peer Review
Applications are reviewed by interdisciplinary expert review committees comprised of BHCRI members representing our diverse geography and disciplines. Reviewers rank applications based on the research proposal, including its relevance to cancer. BHCRI is grateful to members of the Scientific Review Panels for their significant time and effort in reviewing applications.
Since 2009, BHCRI has awarded over $4.7M to cancer researchers in Atlantic Canada.
Equity, Diversity, and Inclusion
BHCRI is committed to diversity in all aspects of its operation, including our people and our support of the full spectrum of cancer research. BHCRI recognizes that many groups are under-represented in research, and we are committed to increasing diversity and inclusion in research. We strive for diversity on all our committees, panels and any events that we organize or plan.
Funding
The Beatrice Hunter Cancer Research Institute relies on the generosity and trust of our partner organizations, who invest in BHCRI programs to support cancer research in Atlantic Canada. BHCRI is a highly regarded peer review and administrative enterprise dedicated to cancer research training, excellence and innovation.
Our thanks to the Dalhousie Medical Research Foundation, and the New Brunswick Health Research Foundation for their support of these awards. To learn more about these organizations and all of our partners, visit our partners page: https://bhcri.ca/funding-partners.
New Investigator 2022 |
|||
|---|---|---|---|
|
Applicant |
Project Title |
Funding Partner |
Value / Term |
|
Vitalité Health Network |
New Brunswick Health Research Foundation |
April 2022 – March 2024 $89,904 |
|
|
Microbiology & Immunology Dalhousie University |
Dalhousie Medical Research Foundation |
July 2022 – June 2024 $100,000 |
|
|
Radiation Oncology Nova Scotia Health and Dalhousie University |
Tumour immune penetration and response to radiotherapy |
Dalhousie Medical Research Foundation |
January 2022 – December 2023 $76,160 |
|
Tobias Karakach, Pharmacology Dalhousie University |
Wilms tumour relapse is exacerbated by the activation of the MAPK pathways via small GTPases |
Dalhousie Medical Research Foundation |
January 2022 – December 2023 $99,675 |
|
Atlantic Cancer Research Institute |
New Brunswick Health Research Foundation |
April 2022 – March 2024 $99,000 |
|
Seed Grants 2022/23 |
|||
|
Applicant |
Project Title |
Funding Partner |
Value / Term |
|
Paola Marcato Pathology Dalhousie University |
LINC01929 is a novel potential mediator of breast cancer progression and tumour immune suppression |
Dalhousie Medical Research Foundation |
Jan 2021 – Dec 2021 $20,000 |
|
Kirill Rosen Pediatrics and Biochemistry & Molecular Biology Dalhousie University |
Heme oxygenase-1-upregulating drugs as novel tools for ErbB2/Her2-positive breast cancer treatment |
Dalhousie Medical Research Foundation |
$20,000 |
|
Kerry Goralski School of Pharmacy Dalhousie University |
Development of a mouse model to study genetic determinates of a 1-asparaginase-induced pancreatitis |
Dalhousie Medical Research Foundation |
Sept 2022 — Aug 2023 $20,000 |
|
Cindy Feng Community Health & Epidemiology Dalhousie University |
Assessing individual and joint effect of modifiable risk factors associated with lung, breast, colorectal and prostate cancer incidence in Atlantic Canada | Dalhousie Medical Research Foundation |
Jan 2023 — Dec 2023 $19,798.40 |
Congratulations to the recipients of 2020 BHCRI/DMRF New Investigator Awards
Congratulations to the recipients of 2018 BHCRI New Investigator Awards
Congratulations to the recipients of 2017 BHCRI New Investigator Awards and Ivor Hamilton Cancer Care & Education Awards
Congratulations to the recipients of 2017 Breast Cancer Society of Canada/QEII Foundation Awards
Congratulations to the recipients of 2016 New Investigator Awards
Congratulations to the recipients of 2016 Breast Cancer Society of Canada/QEII Foundation Awards
Congratulations to the recipients of 2015 New Investigator Awards
Congratulations to the recipients of 2015 Breast Cancer Society of Canada/QEII Foundation Awards